PSA testing – The Focus Insight

Prostate cancer screening limited to a few thousand high risk men

2026년 05월 29일 by team insight

A group of men in a healthcare setting discusses prostate cancer screening options with a medical professional, highlighting the recent changes in guidelines for highrisk individuals.

The U.S. Preventive Services Task Force (USPSTF) updated its recommendations in September 2023, indicating that men aged 55 to 69 should discuss the potential benefits and harms of prostate-specific antigen (PSA) screening with their healthcare providers. For those interested in understanding the broader implications of health guidelines, this article provides insights on how healthcare recommendations … Read more

Understanding prostate cancer and its diagnosis in the UK

2025년 11월 26일 by team insight

As of 2023, the primary diagnostic methods for prostate cancer in the UK include prostate-specific antigen (PSA) testing, digital rectal examinations (DRE), and, in some cases, MRI scans. The National Health Service (NHS) has been advocating for increased awareness of these diagnostic tools, particularly among men over the age of 50, who are at a … Read more